Ces radiol. 2008, 62(4):329-333
Effect of intravascular iodinated contrast media on residual renal function in hemodialysed patients - a prospective studyOriginal article
- 1 Základna radiodiagnostiky a intervenční radiologie IKEM, Praha
- 2 Radiologická klinika LF a FN, Hradec Králové
- 3 Radiodiagnostické oddělení, Pardubická krajská nemocnice a.s., Pardubice
- 4 Fresenius Medical Care, D.S., Pardubice
- 5 Gerontometabolická klinika LF a FN, Hradec Králové
- 6 Katedra biofyziky FN, Hradec Králové
Aim: To evaluate impact of intravascular iodinated contrast medium on residual renal function in hemodialysed patiens.
Method: Two groups of hemodialysed patiens with clinically significant residual renal function (minimally 500 ml of urine per day) were studied. The patients from the first group were given isoosmolal contrast agent iodixanol (Visipaque GE Healthcare, United Kingdom) in concentration of iodine 320 mg/ml with osmolality 290 mOsm/kg of water during endovascular procedure. The second control group was followed without contrast medium administered. The evaluated group included 42 patients whom were given 99.3 ml of iodixanol in average (range from 60 to 180 ml). The control group included 45 patients. Residual diuresis and clearance of creatinine had been evaluated in the both groups following 6 months.
Results: There was no statistically significant difference found between both groups in daily volume of urine (p = 0.855) and clearance of creatinine (p = 0.573).
Conclusion: Residual diuresis is not significantly influenced by intravascular administration of isotonic iodinated contrast agent (iodixanol) in range of volume from 60 to 180 ml in comparison to natural decrease of residual renal functions.
Keywords: hemodialysis, iodixanol, residual diuresis, residual renal functions
Accepted: October 15, 2008; Published: December 1, 2008 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Morcos SK, Thomsen, H S, Webb JW. Contrast-media-induced nephrotoxicity: a consensus report. Eur Radiol 1999; 9: 1602-1613.
Go to original source...
Go to PubMed...
- Rodby RA. Preventing complications of radiographic contrast media: Is there a role for dialysis? Sem Dialysis 2007; 20: 19-23.
Go to original source...
Go to PubMed...
- Chandra SM, Farrington K. Residual renal function: Considerations on its importance and presevation in dialysis patients. Sem Dialysis 2004; 3: 196-201.
Go to original source...
Go to PubMed...
- Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int 2006; 69: 1726-1732.
Go to original source...
Go to PubMed...
- Wang AY, Wang M, Woo J, et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 2002; 62: 639-642.
Go to original source...
Go to PubMed...
- Dittrich E, Puttinger H. Effect of radio contrast media on residual renal function in peritoneal dialysis patients. Nephrol Dial Transplant 2006; 21: 1334-1339.
Go to original source...
Go to PubMed...
- Moranne O, Willoteaux S. Effect of iodinated contrast agents on rezidual renal function in PD patients. Nephrol Dial Transplant 2006; 21: 1040-1045.
Go to original source...
Go to PubMed...
- Weisbord SD, Bernardini J, Mor MK, et al. The effect coronary angiography on residual renal funnction in patients on peritoneal dialysis. Clin Cardiol 2006; 29: 494-497.
Go to original source...
Go to PubMed...
- Hamani A, Petitclerc T, Jacobs C, Deray G. Is dialysis indicated immediately after administration of iodinated contrast agents in patients on haemodialysis? Nephrol Dial Transplant 1998; 13: 1051.
Go to original source...
- Harazawa Z, Zamazali C, Mazuki K. Side effects and pharmacokinetics of non ionic contrast medium in hemodialyzed patiens. Nippon Igazku Hoashasen gakkai Zasshi 1990; 50: 1524-1531.
- Vogt B, Ferrari P, Schonholzer C, et al. Pre-emptive haemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 11: 692-698.
Go to original source...
Go to PubMed...
- Morduchowicz G, Winkler J, Zabludowski JR, Boner G. Effects of residual renal function in hemodialysis patients. Int Urol Nephrol 1994; 26: 125-131.
Go to original source...
Go to PubMed...
- Erkan E, Moritz M, Kastel F. Impact of residual renal function in children on hemodialysis. Pediatr Nephrol 2001; 16: 858-856.
Go to original source...
Go to PubMed...
- Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658.
Go to original source...
Go to PubMed...
- Arici M, Walls J. End-stage renal disease, atherosclerosis and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int 2001; 59: 407-414.
Go to original source...
Go to PubMed...
- Suda T, Hiroshige K, Ohta T, et al. The contribution of residual renal function on overall nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant 2000; 15: 396-401.
Go to original source...
Go to PubMed...
- Deray G. Dialysis and iodinated contrast media. Kidney Int 2006; 68: S25-S29.
Go to original source...
Go to PubMed...
- Dawson P. Contrast agents i patients on dialysis. Sem Dialysis 2002; 15: 232-246.
Go to original source...
Go to PubMed...
- Eley CM. Does hydratation prevent radiocontrast-induced acute renal failure? Nephrol Dial Transplant 1999; 14: 1064-1066.
Go to original source...
Go to PubMed...
- Aspelin P, Aubry P, Frannson SG. Nephrotoxic effects in high-risk patients undergoing angiography, N Eng. J Med 2003; 348: 491-500.
Go to original source...
Go to PubMed...
- Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349: 1330-1340.
Go to original source...
Go to PubMed...
- Morcos SK, Thomsen H S, Webb JAW. Dialysis and contrast media. Eur Radiol 2002; 12: 3026-3030.
Go to original source...
Go to PubMed...
- Yuonathan CM, Kaude JV, Cook MR, et al. Dialysis is not indicated immediately after administration of non-ionic contrast agents in patients with end-stage renal disease treated by maintainance dialysis. Am J Roentgenol 1994; 163: 969-971.
Go to original source...
Go to PubMed...
- Barret BJ, Katzberg RW, Thomsen HS, et al. Contrast induced nephropathy in patients with chronic kidney disease undergoing computed tomography. A double blind comparison of iodixanol and iopamidol. Invest Radiol 2006; 41: 815-821.
Go to original source...
Go to PubMed...
- Briguori C, Kolombo A, Airoldi F, et al. Nephrotoxicity of low-osmolality versus isoosmolality contrast agents: impact of N-acetylcysteine. Kidney Int 2006; 68: 2250-2255.
Go to original source...
Go to PubMed...
- Jo SH, Yuon TJ, Koo BK, et al. Renal toxicity evaluation and comparsion between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography. The RECOVER study: A randomized controlled trial. J Am Coll Cardiol 2006; 48: 924-930.
- Thomsen HS, Morcos SK, Eley ChM, et al. The ACTIVE Trial: Comparison of the effect on renal function of Iomeprol-400 and Iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 2008; 43: 170-178.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.